LGND Chart
- 52-Week Range: $78.68 - $165.85
- Market Capitalization: $1.41B
- Short Percentage: 0%
- Target Price: $184.29
- Shares Outstanding: 16.86M
- Next Earnings: Feb 3
Catalysts
CategoryCatalyst
Earnings
LGND released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Ligand Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Business Wire | April 8th
- Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 17th
- Ligand: Green Shoots And A Hidden Treasure - A Spinoff Bonus For The New YearSeeking Alpha | December 31st
- Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha | November 9th
Company Info
Website: https://www.ligand.com
Address: 5980 Horton Street, EmeryVille, CA, United States, 94608
Sector: Healthcare
Industry: Biotechnology
Full time employees: 154
Address: 5980 Horton Street, EmeryVille, CA, United States, 94608
Sector: Healthcare
Industry: Biotechnology
Full time employees: 154
$LGND diamond balls
$LGND I’ll be buying more if this dips!
$LGND Powell save me
$LGND We will not sell!
$LGND Who’s still buying calls?
$LGND just waiting to short this bad boy.
$LGND buy more doomers!!!
$LGND has just been halted from trading.
$LGND we all speculate but nobody knows what going to happen.
$LGND good place to average up